ClinicalTrials.govpublic full text
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's Disease
parkinson disease, anle138b, alpha-synuclein, oligomer modulator, multiple system atrophy, alzheimer disease, neurodegenerative diseases, tauopathies, amyloid, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 894024
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.